RecruitingNot ApplicableNCT06788418

Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction

Sponsor

Beijing Visionly Plus Eye Hospital

Enrollment

1,000 participants

Start Date

Jan 20, 2025

Study Type

INTERVENTIONAL

Conditions

Myopia

Summary

Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.

Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called ICL, a procedure called SMILE, and others for people with myopia. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.